Startups
BigHat is a Bay-area startup that’s reimagining antibody development with the help of AI and ML (machine learning) technologies through data-driven discovery.
The duo launch Riverway Discoveries to drive the development and commercialization of new cancer therapeutics faster into patient’s hands.
The combined company will be called Gemini Therapeutics, Inc. and will trade under the ticker symbol, GMTX.
A brief rundown of who’s raking in cash in the biopharma world.
Nirogy Therapeutics, based in Boston, launched with a $16.5 million Series A financing round. The round was co-led by Santé Ventures and Sporos.
The 2021 trend of biotech initial public offerings (IPOs) continued this week. Here’s a look.
Seattle startup AltPep targets amyloid deposits to treat Alzheimer’s Disease.
Biopharma companies raking in the cash with investment rounds and IPO announcements.
Sana Biotechnology has filed with the U.S. Securities and Exchange Commission to raise up to $150 million in an initial public offering to help support the company’s cell-based therapy discovery and development operations.
Flagship Pioneering launched a new company called Inzen Therapeutics, which will discover and develop a new class of medicines based on a new area of biology that will provide new therapeutic approaches to multiple types of diseases.
PRESS RELEASES